Rocket Pharmaceuticals Shares Rise After Needham Upgrade
MT newswire2026/09/16 18:09Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
02:09 PM EDT, 09/16/2026 (MT Newswires) -- Rocket Pharmaceuticals (RCKT) shares were up almost 2% in Wednesday trading after Needham upgraded the stock to buy from hold, with a price target of $9. Trading volume stood at more than 1.7 million shares, compared with a daily average of about 2 million. Price: 3.48, Change: +0.07, Percent Change: +1.91
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nvidia (NVDA.US) further strengthens AI infrastructure by investing $2 billion in Brookfield (BAM.US) Global AI Fund, which aims to raise $10 billion.
Nvidia has invested $2 billion in the Global Artificial Intelligence Infrastructure Fund under Brookfield Asset Management.
智通财经•2026/09/17 22:26
LCNB Chief Wealth Officer Michael Miller to Retire
MT newswire•2026/09/17 21:53
Loop Industries to Evaluate Alternatives, India Joint Venture Financing
MT newswire•2026/09/17 21:28
